Michael John La Brier

All filings by Michael John La Brier on record concern Supreme Pharmaceuticals Inc. In total, 6 filings cover trades dated from 25 April 2016 to 18 October 2017.

No open-market purchase appears, only 1 sale. The totals do not cover 1 filing with an undisclosed amount. 2017 to date brings no purchases and 1 sale.

The latest filing, published on 15 November 2017, reports an open-market sale in Supreme Pharmaceuticals Inc. Typically, a trade is published a median of 9 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.